The relationship between the intralobular sites of hepatotoxic injury and the distribution of microcystin-LR (MCLR), an inhibitor of protein phosphatases 1 (PPl) and 2A (PPZA), was examined using an immunohistochemical method with a monoclonal antibody specific to MCLR on the livers of mice receiving a single ip injection of the MCLR. Immunoblotting and high-performance liquid chromatography analyses of liver extracts were also performed to determine the binding form of MCLR to PPI and PP2A (MCLR-PPIIPP2A adducts) and free MCLR. Immunohistochemistry revealed a discernible intensity of staining in the centrilobular regions where hemorrhage and apoptosis occurred. In these regions, imrilunopositivity was evident in the cytoplasm-and nuclei of the hepatocytes: some apoptotic cells were also immunopositive. In contrast, coagblative necrosis, which was mainly evident in the midlobular regions, was completely negative. Analysis of liver extracts demonstrated MCLR-PPIIPP2A adducts, but free MCLR was below detection limit. These results suggest that the immunohistochemical localization of MCLR in centrilobular hepatocytes is closely associated with the onset of hemorrhage and apoptosis and is related to adduct formation. The occurrence of coagulative necrosis however might also be related to other factors such as ischemiafhypoxia.
INTRODUCTION
Microcystins (MCs) are naturally occurring cyclic heptapeptides produced by cyanobacteria such as Microcystis aerugiizosa blooming in nutrient-enriched reservoirs and lakes. MCs have hepatotoxic and tumor-promoting activity in animals and are potent human health hazards in drinking water (1, 4, 5, 30, 34) . Recently, we established a highly sensitive enzyme-linked immunosorbent assay (ELISA) based on a monoclonal antibody (MAb) specific to MCs (anti-MC MAb) (16, 17) . Surveys of MC levels in environmental water using this method revealed worldwide contamination by MCs in various water sources for recreation and drinking use (3 1, 33). A positive correlation between the level of MCs in drinking water and the risk of primary liver cancer in endemic areas in China has been found (32).
Microcystin-LR (MCLR) is one of the most toxic groups of MCs (34). A single injection of MCLR produces hemorrhage and coagulative necrosis in the liver and emboli of hepatocytes within pulmonary alveolar septa in rats and mice (7, 8, 14, 27, 36) . A recent study with irt sitii end labeling (ISEL) and electron microscopy indicated that apoptotic cell death appeared in association with hepatocellular coagulative necrosis in mice (36) . It has been proposed that MCLR toxicity occurs following its covalent binding to protein phosphatases 1 (PPI) and 2A (PP2A) (MCLR-PPllPP2A adducts) (3, 15, 21), thereby inhibiting PPl and PP2A activity and subse- quently leading to hyperphosphorylation of cytoskeletal proteins (5, 34) , rearrangement of intennediatehctin filaments and microtubules, and finally alteration of cell structure (9, 11, 35) . Although alterations of hepatocyte actin filaments have been demonstrated in the hemorrhagic rat livers (9) , it is still unclear whether MCLR is responsible for the observed occurrence of hemorrhage, coagulative necrosis, and apoptosis.
With the objective of elucidating the pathogenesis of MCLR-induced hepatotoxicity, we conducted an immunohistochemical study with an anti-MC MAb on tissues: from mice injected with MCLR. The objective of this study was to document the intralobular and intracellular localization of MCLR and its association with hepatocellular injuries. In addition, we measured MCLR-PPl/ PP2A adducts and free MCLR in liver extracts using immunoprecipitationhnmmunoblotting and high-performance liquid chromatography (HPLC). A part of the present data was previously reported (29).
METHODS

Histology.
Tissue samples for the present study were obtained from original paraffin blocks used in a previous study (36). Six-week-old female BALB/c mice were given a single ip injection of MCLR at 0, 40.0, 48.0, 57.6, 69.1, or 82.9 p g k g followed by a 24-hr observation period or were given an ip injection of 0, 20.0, 30.0, 45.0, 67.5, or 101.3 p g k g followed by 7 days of observation. Liver and lung tissues from mice found dead within 6 hr and from survivors at 24 hr or 7 days after dosing were immediately fixed in 10% neutral buffered formalin. The tissues were embedded in paraffin, sectioned at 5 pm, and stained with hematoxylin and eosin (H&E) and examined using immunohistochemistry for MCLR and using ISEL for apoptosis.
Biotinylated anti-MC MAb M8H5, showing the highest affinity to MCLR (affinity constant = 3.1 X 1O' O) among MAbs raised against MCLR (16), was used for immunohistochemistry. Paraffin-embedded sections were routinely rehydrated and incubated with 0.05% pronase in phosphate-buffered saline (PBS) and 4% BlockAce (Dainippon Pharmaceutical, Osaka, Japan) solution. Sections were then incubated at 4°C overnight in biotinylated anti-MC MAb solution (40.0 pg/ml), followed by visualizing with streptoavidin-alkaline phosphatase (ALP) conjugate and substrate Vector blue (Vector Laboratories, Burlingame, CA, USA). The sections were counterstained with Kernechtrot solution. A positive reaction to bound anti-MC MAb was recognized as a blue color against a red counterstained background. Apoptotic cells/ bodies were identified by morphologic features and ISEL (6) . ISEL was performed using an in sitii cell detection kit (Boehringer Mannheim GmbH, Mannheim, Germany). Liver sections were deparaffinized, treated with pronase, and incubated with a 0.3% H,O,-methanol solution and a 4.0% BlockAce solution. The sections were stained using the cell detection kit with the chromogen diaminobenzidine and were counterstained with Kernechtrot solution. Apoptotic cellshodies were identified as a brown color and confirmed by identifying characteristic morphologic features of apoptosis in H&E-stained serial sections. To determine colocalization of apoptosis and MCLR, slides were first stained by the ISEL method (brown color) followed by immunohistochemistry with anti-MC MAb (blue color). The double-stained regions were identified as dark blue color.
Preparation of Liver Extracts. A 10-wk-old female BALB/c mouse (Japan CLEA) was injected ip with 50 p g k g or 1 mg/kg of MCLR dissolved in saline (12) . A control mouse was given saline alone. The mouse given 50 p g k g was euthanatized 60 min after the injection, when the liver was grossly normal. The mouse giveii 1 mgkg died 45 min after the injection; the liver was grossly dark red and enlarged as previously reported (8, 27). Weighed portions of the liver were homogenized with 10 volumes of lysis buffer as previously reported (21) and then centrifuged at 10,000 X g for 10 min. The supernatants were subjected to immunoprecipitatiordimmunoblotting and HPLC. Because a tracer study using 35 pg/ kg of radiolabeled MCLR demonstrated high hepatic accumulation of the toxin even 60 min after iv injection (20), the dose of 50 pg/kg is thought to be useful for immunoblotting. The higher dose of 1 mgkg was selected for immunoprecipitation/immunoblotting and HPLC based upon a previous report of immunoaffinity purification using anti-MC MAb coupled with HPLC (12) .
MCLR-PPUPP2A Addircts in the Liver. Anti-MC MAb was used to detect proteins binding with MCLR in the liver. Liver tissue extracts from the treated mouse (50 pg/kg) and control mouse were mixed with an equal volume of sample buffer consisting of 125 mi Tris-HC1 (pH 6.8), 4% (w/v) sodium dodecyl sulfate (SDS), 20% (v/v) glycerol, 0.005% (w/v) bromophenol blue, and 10% (v/ v) 2-mercaptoethanol and boiled for 5 min. The proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE) with 10% gel and then blotted onto PVDF membranes (Millipore Co., Bedford, MA, USA). After blocking with 5% skim milk in PBS, the blots were incubated with or without biotinylated anti-MC MAb (3.3 pg/ml), followed by visualizing with streptoavidin-ALP conjugate and a 5-bromo-4-chloro-3-indoxyl phosphate/ nitro blue tetrazolium chloride (BCIP/NBT) substrate system (Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA). Immunoprecipitation was performed to detect MCLR-PPUPP2A adducts in the liver. Liver tissue extracts from the treated mouse (1 mgkg) and control mouse were mixed with an equal volume of denaturalized buffer consisting of 125 nzhf Tris-HC1 (pH 6.8), 4% (w/ v) SDS, and 10% (v/v) 2-mercaptoethanol and boiled for 5 min. The samples were dialyzed against PBS-Tween and incubated with anti-MC MAb-coupled immunoaffinity gel for 10 min as previously described (12) . After washing with PBS-Tween, the precipitates were analyzed by SDS-PAGE followed by immunoblotting. The blots were incubated with either anti-MC MAb or rabbit antibody specific to PPl or PP2A (Seikagaku, Tokyo, Japan; diluted 1/300) and then visualized with ALP-conjugated goat anti-rabbit IgG (Southern Biotechnology Associates, Birmingham, AL, USA) and the BCIP/NBT substrate system.
Free MCLR it1 the Liver. The amount of free MCLR in the liver was estimated by HPLC. Two-milliliter extracts from the treated mouse (1 m a g ) and control mouse were used. The positive control for this analysis was a volume of MCLR (0.75 pg/ml in PBS) that was selected based upon the assumption that MCLR (1 mgl kg) completely accumulates in hepatic tissues. Before HPLC analysis, the samples were cleaned up with an octadecyl silanized (ODS) cartridge, immunoaffinity purified with the anti-MC MAb as described previously (12), and evaporated to dryness; the residue was dissolved in -200 p1 methanol. Each sample (10 ~1 ) was injected into a Capcell Pack C18 ODS column (Shiseido Corp., Tokyo, Japan) maintained at 42"C, and peaks obtained were compared with those of the positive control. The HPLC system was operated in an isocratic mode with methanol-0.01 hi phosphate buffer (pH 3.0, 6:4) at a flow rate of 1 mVmin and with UV detection at 238 nm (17). The detection limit was quantitatively 10% of the positive control.
RESULTS
Histology
Early Deaths. The liver from mice that were given a lethal dose of MCLR (57.6-101.3 pgkg) and died within 6 hr after injection had severe hemorrhage in the centrilobular regions of the liver (Fig. la) . Immunopositive reaction with anti-MC MAb was observed in the cytoplasm and more intense staining was observed in nuclei of he-.' patocytes in the centrilobular regions where hemorrhage occurred (Fig. lb, c) . Cytoplasmic staining for MCLR was heterogeneous, with a granular pattern. Both positive and negative hepatocyte nuclei were noted; binucleated hepatocytes often contained a positive and negative nucleus. Free or degenerative hepatocytes within large intrahepatic veins and alveolar capillaries, presumably derived from the affected liver (7, 8, 27) , were also immunopositive with anti-MC MAb (Fig. Id, e) ; however, the staining of hepatocyte emboli in the lung was relatively weak. Survivors, 24 Hr. Focal, massive, and zonal hepatocellular coagulative necrosis was observed in the livers from mice that were given sublethal doses of 57.6 and 69.1 p g k g and survived for 24 hr. Necrotic changes were mainly located in the midlobular regions, often with extension towards the central veins (Fig. 24 . Free hepatocytes were also observed within large intrahepatic veins. The positive reaction to anti-MC MAb was observed in the centrilobular regions and occasionally in perinecrotic areas near central veins, whereas no staining was recognized within necrotic areas (Fig. 2b) . Single cell death, with morphologic features of apoptosis, was present in the centrilobular regions and in the border zone between necrotic and intact areas (Fig. 2c) as described previously (36). In these areas, there were many intensely immunopositive round bodies and positive cytoplasmic granules, considered to represent apoptotic cellshodies (Fig.  2d) . Intensely immunopositive round bodies were also noted in sinusoids. The livers from mice given 40.0 and 48.0 p g k g showed similar centrilobular apoptosis and immunopositivity.
Survivors, 7 Days. The livers from mice that'were given sublethal doses (20.0, 30.0, and 45.0 pgkg) of MCLR and that survived for 7 days had multiple apoptotic cells/ bodies in the centrilobular regions where hypertrophic hepatocytes were prominent (Fig. 3a) . Anti-MC MAbpositive round bodies and granules were also localized in extracellular and intracellular spaces in the centrilobular regions and perinecrotic areas. Some of round bodies and granules that stained with anti-MC MAb were unequivocally labeled by the ISEL method at 24 hr and 7 daysafter MCLR administration (Fig. 3b) . Rare ISEL-positive apoptotic cellshodies that were immunonegative for MCLR were seen at 7 days after injection. In the livers from control mice, a few ISEL-positive apoptotic cells/ bodies were randomly scattered in hepatic lobules.
Detection of MCLR-PPI/PP2A Addircts and Free MCLR
Immunoblotting of the liver from mice given 50 pg/ kg MCLR revealed that anti-MC MAb was recognized as a protein of approximately 40 kDa (Fig. 4) . Bands >49 kDa were recognized by streptoavidin-ALP conjugate alone. Immunoprecipitation of the livers from mice given MCLR at 1 m g k g using anti-MC MAb revealed specific bands at about 40 kDa that cross-reacted with anti-PP1 and anti-PP2A antibodies (Fig. 5) . These findings suggest that anti-MC MAb presumably recognizes MCLR-PPl/ PP2A adducts. Although a peak of free MCLR was detected by HPLC analysis in the livers from mice given MCLR at 1 mg/kg, the free MCLR was quantitatively below the detection limit (Fig. 6) . Positive immunostaining with anti-MC MAb was consistently observed in the centrilobular hepatocytes in association with the occurrence of hemorrhage or apoptosis. This distribution of MCLR suggests that cytoplasmic and nuclear accumulation may directly contribute to hepatocyte dysfunction, followed by disruption of hepatic cords (hemorrhage) or apoptotic cell death. This interpretation is consistent with previous data showing that MCLR dramatically deformed centrilobular hepatocytes by altering cytoskeletal filaments (7, 9) . Furthermore, the uptake into hepatocytes and the intracellular concentration of MCLR might have a threshold that is critical in the emergence of either hemorrhagic necrosis or apoptosis.
In contrast, the areas of coagulative necrosis were mainly located in the midlobular regions; these areas were completely negative with anti-MC MAb. This absence of an immunopositive reaction to MCLR is most likely due to loss of the antigenic epitope of preexisting MCLR secondary to the necrotic process. Nevertheless, if coagulative necrosis is attributed to accumulation of MCLR, it would occur mainly in the centrilobular regions similar to the situation in acetaminophen-treated livers that has been documented using a similar immunohistochemical method (19) . Additionally, hepatocellular apoptosis and necrosis as found in thioacetamide-treated livers are thought to be induced sequentially (13). The site of coagulative necrosis in the present study seems to be similar to that in the experimental ischemic/hypoxic liver; .cell death was first prominent in the midlobular regions and then extended towards the-centrilobular regions (25). If mice treated with a sublethal dose of MCLR first undergo hypovolemic shock due to mild hemorrhage in the centrilobular regions or to intralobular formation of microemboli consisting of exfoliated hepatocytes, then ischemidhypoxia may arise and predispose hepatic tissues to coagulative necrosis.
In this study, 2 types of apoptotic cellshodies were recognized: 1 was stained with anti-MC MAb, and the other was not labeled. Although the significance of apoptosis has not been fully elucidated in toxicology (6, 28), 1 of the roles of apoptosis in chemical tissue damage was discussed in cadmium (Cd) renal toxicity (26). The authors suggested that apoptotic renal epithelial cells containing Cd may exfoliate into the renal tubules and facilitate the excretion of Cd into urine (26). Because apoptotic hepatocytes would be finally phagocytized and degraded by neighboring hepatocytes and macrophages (6, 28), apoptotic cellshodies containing MCLR may indicate a phenotype of cytotoxicity and may have a role in the elimination of the toxin from the liver. Moreover, the presence of apoptotic hepatocytes that contain MCLR 7 days after MCLR administration suggests both a prolonged intracellular accumulation of MCLR, as documented in a previous report of radiolabeled toxin (20), and subsequent degradation of the toxin. Alternatively, the apoptotic cellshodies not stained with anti-MC MAb may indicate both degradation of the antigenic epitope of MCLR through the apoptotic process (22) and association with other endogenous stimuli triggering apoptosis. Experimental ischemiahypoxia could induce apoptotic cell death and necrosis in the liver (10) . Because ischemia/ hypoxia may mediate coagulative necrosis after exposure of MCLR, this endogenous factor may be associated with an onset of some degree of apoptosis. Furthermore, the toxic environment with nitric oxide, oxygen radicals, and cytokines following exposure of MCLR (34) may be responsible for inducing apoptosis. Although the mechanism of apoptosis remains uncertain, studies using anti-MC MAb may help clarify the toxicological importance of apoptotic cell death.
With regard to intracellular distribution of MCLR, the discernible intensity of staining in the nucleus of hepatocytes appeared to be remarkably higher than that in the cytoplasm. Our results showed that the immunoreactivity with anti-MC MAb was specific for MCLR-PP WP2A adducts in accordance with a previous study in which .. radiolabeled microcystin-YM was used (21), whereas HPLC analysis demonstrated that free MCLR was quantitatively below the detection limit. Furthermore, PP1 and PP2A localize in both nucleus and cytoplasm, and the nuclear activity of PP1 is at least 5-fold higher than the average extranuclear activity (2, 23, 24) . Therefore, the present immunohistochemical result could reflect a possible distribution of MCLR-PPIPP2A adducts associated with intracellular localization of protein phosphatases. In contrast, the specific binding potential of radiolabeled MCLR in the cytosolic fraction is many times higher than that of the particulate fraction including nuclei (1 8) . The discrepancy between these results and findings of the present study is uncertain.
Inhibition of PP1 and PP2A is implicated in the toxicity of hepatocytes exposed to MCLR (5, 34), and formation of adducts may also contribute to toxicity (3, 15, 21 ). An unusual Adda (3-amino-9-methoxy-2,6,8-trimethyl-1O-phenyldeca-4,6-dienoic acid) of MCLR is responsible for recognizing and inhibiting PP1 and PP2A with high affinity and potency. Subsequently, methyl-dehydroalanine residues on MCLR are responsible for forming a stable covalent link to catalytic subunits of PP1 and PP2A, resulting in formation of the adducts (3, 15, 21). In addition, the anti-MC MAb we used recognizes the Adda and its neighboring peptides as the active center of the MC molecule (16). The present data suggest that immunohistochemical localization of MCLR may reveal the distribution of protein adducts and simultaneously indicate the occurrence site of cytotoxicity.
